Funding
← Back to your selection

Pfizer Ventures

Activity from announced rounds

Activity in this selectionAI

Pfizer Ventures is the venture unit whose official portfolio includes TRIMTECH and TwoStep and whose partner Rana Al-Hallaq is identified in company materials.

Recorded funding activity

TwoStep develops targeted cancer therapies. TRIMTECH develops protein-degrading medicines for neurological disease, while Crossbow develops cancer antibodies. These relationships remain distinct from generic Pfizer corporate participation.

Sources
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$101.2M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series B1

By primary sector

Biotech2

By country

France1
United States1

Rounds

2 in this selection
Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Role not disclosed